[ASAP] Polymer–Drug Conjugates Codeliver a Temozolomide Intermediate and Nitric Oxide for Enhanced Chemotherapy against Glioblastoma Multiforme

AI Summary

This article discusses the use of polymer-drug conjugates to deliver a temozolomide intermediate and nitric oxide for improved chemotherapy against glioblastoma multiforme. The combination of these two components aims to enhance the effectiveness of treatment for this aggressive form of brain cancer.

Leave a Reply